Cargando…
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials
Background: Psoriasis is a chronic, immune-mediated skin disease that may occur at any age. Prevalence in children ranges between 0.5 and 1.0% across Europe. Approximately 10–20% of paediatric psoriasis patients are moderate-to-severe in severity and may require the use of systemic therapy. Objectiv...
Autores principales: | Di Lernia, Vito, Macca, Laura, Peterle, Lucia, Ingrasciotta, Ylenia, Trifirò, Gianluca, Guarneri, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017712/ https://www.ncbi.nlm.nih.gov/pubmed/35450044 http://dx.doi.org/10.3389/fphar.2022.847308 |
Ejemplares similares
-
Hidradenitis suppurativa and psoriasis: the odd couple
por: Macca, Laura, et al.
Publicado: (2023) -
Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo
por: Macca, Laura, et al.
Publicado: (2022) -
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease
por: Motolese, Alfonso, et al.
Publicado: (2022) -
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy
por: Ingrasciotta, Ylenia, et al.
Publicado: (2021) -
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review
por: Macca, Laura, et al.
Publicado: (2022)